LOGIN
Denosumab and teriparatide significantly improves BMD in patients with osteoporosis
July 2014
Denosumab and teriparatide significantly improves BMD in patients with osteoporosis
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
J Clin Endocrinol Metab. 2014 May;99(5):1694-700Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
94 postmenopausal women, >45 years of age, who had been diagnosed with osteoporosis and who were at high risk for fracture, were randomly assigned into 1 of 3 treatment groups to determine the long term effect (24 months) a combination of denosumab and teriparatide had on hip and spine BMD. Patients either received a combined drug treatment of denosumab and teriparatide, or intervention with denos...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.